Skip to NavigationSkip to content

News

0
Sees FY 2016 total revenue of $10.5 billion to $11.5 billion 
0
The newly formed Quintiles IMS to combine the former’s clinical trial services with the latter’s industry information and research
0
The device could potentially be implanted to the eye
0
Zinbryta (daclizumab) reduced the annualised relapse rate of patients with MS in clinical trials

Features

Medicins Sans Frontieres takes a stand against Pfizer’s filing of an Indian patent on a highly effective pneumonia vaccine.